Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.38 |
| ▸ | MMP9 | P14780 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | LAP3 | P28838 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13185402 | 1.00 | MMP3 (0.44) | MMP3ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL15834154 | 1.00 | MMP3 (0.44) | MMP3ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL23084216 | 0.84 | ALDH1A1 (0.47) | MMP3ALDH1A1MEN1LMNAKMT2A | |
| SCHEMBL6507883 | 0.83 | BCHE (0.39) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL8768456 | 0.83 | ALDH1A1 (0.41) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL17826032 | 0.83 | MAPT (0.44) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL8768447 | 0.83 | ALDH1A1 (0.41) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6035952 | 0.80 | BCHE (0.50) | MMP3ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL13374712 | 0.80 | BCHE (0.50) | MMP3ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL27696190 | 0.80 | BCHE (0.50) | MMP3ALDH1A1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281292-A1 | 10a-Azalide Compound | IL17A, AZI2, HDAC9 | MMP3 160/4885ALDH1A1 1939/4885MEN1 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.